EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE 1.2 MG AND EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Shi, L. W.
Han, S.
Liu, F.

Open link

Publication date

January 2014

DOI

10.1016/j.jval.2014.08.161

Publisher

value in health

ISSN

1098-3015

Journal

issn:1524-4733

Abstract

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346917303255&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=8e1609b174ce4e31116a60747a720701EconomicsHealth Care Sciences & ServicesHealth Policy & ServicesSCI(E)PubMedSSCI0MEETING ABSTRACT7A744-A7451

Extracted data

We use cookies to provide a better user experience.

Data Protection

EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE 1.2 MG AND EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Abstract

Extracted data

EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF LIRAGLUTIDE 1.2 MG AND EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Abstract

Extracted data

Related items

Related items